Device Judgement Recommended
|
|
- Emma Caldwell
- 6 years ago
- Views:
Transcription
1 dabl Educational Trust Validation Checklist Device Judgement Recommended Manufacturer IEM Device Stabil O Graph Category Upper Arm (Self) Mode Oscillometric Protocol Reference BHS + ESH Westhoff TH, Schmidt S, Zidek W, van der Giet M. Validation of the Stabil O Graph blood pressure self measurement device Journal of Human Hypertension 2007;22, ,Research Letter Recruitment Screened 112 (BHS), 41 (ESH) Included 85 (BHS), 33 (ESH) Excluded Explained Some Ranges Correct Yes Ages Correct Yes Sexes Correct Yes Description of Methods Good Procedure Description Good Problems Explained Results Description Good Plots Plots are absent from the letter. These were requested and are included below. Result Pass Both BHS and ESH and also on ESH subgroup from BHS sample Signoff Notes Without plots or subsections, the letter format is not an ideal method of prsenting the results but it does benefit from consiseness. Problems with a fall in pressure in the ESH study high range subjects are addressed with a confirmatory analyis using a subset from BHS study subjects. Date 14/5/2008 Plots and were requested from the authors. These and tables from the original manuscript are included below dabl Educational Trust., 34 Main Street, Blackrock, Co. Dublin
2 Tables Table 1A: Number of patients required and number of patients examined in each blood pressure group of the BHS protocol Systolic BP Diastolic BP Minimum Number of Number of (mmhg) (mmhg) number of subjects subjects subjects examined examined required (systolic) (diastolic) < 100 < >180 > Table 1B: Grading criteria of the BHS. To obtain a grade, the device must achieve percentages those reported in the table in all the three categories. Grade Percentage of readings with differences between standard and test device of 5 mmhg 10 mmhg 15 mmhg A 60% 85% 95% B 50% 75% 90% C 40% 65% 85% D Worse than C Worse than C Worse than C 17
3 Table 1C: Results of the BHS validation procedure, n=85 subjects. Numbers in column 1 correspond to number of measurement in the BHS protocol (Device measurements versus preceding and succeding Observer measurements) Mean ± SD of Grade Mean ± SD (mmhg) differences (mmhg) Observer 1 SBP (1 vs 2, 3 vs 4, 5 vs 6) DBP (1 vs 2, 3 vs 4, 5 vs 6) SBP (2 vs 3, 4 vs 5, 6 vs 7) DBP (2 vs 3, 4 vs 5, 6 vs 7) Observer 2 SBP (1 vs 2, 3 vs 4, 5 vs 6) DBP (1 vs 2, 3 vs 4, 5 vs 6) SBP (2 vs 3, 4 vs 5, 6 vs 7) DBP (2 vs 3, 4 vs 5, 6 vs 7) Final grading B 61% 88% 94% 100% ± ± 7.2 A 67% 94% 98% 100% 83.9 ± ± 5.8 A 66% 89% 96% 100% ± ± 6.6 A 67% 95% 99% 100% 83.5 ± ± 5.6 B 61% 88% 93% 100% ± ± 7.3 A 65% 94% 98% 100% 84.0 ± ± 5.8 B 66% 87% 94% 100% ± ± 6.6 A 64% 96% 99% 100% 83.5 ± ± 5.8 SBP A 66% 89% 96% 100% ± ± 6.6 DBP A 65% 94% 98% 100% 84.0 ± ±
4 Table 2A: Number of measurements required and achieved for systolic (SBP) and diastolic (DBP) blood pressure falling in specified error-categories according to phase 1 of the ESH protocol (number of subjects n=15, number of measurements n=45). Error category < 5 mmhg < 10 mmhg < 15 mmhg Required One of Achieved SBP DBP Table 2B: Number of measurements required and achieved for systolic (SBP) and diastolic (DBP) blood pressure falling in specified error-categories according to phase 2.1 of the ESH protocol (number of subjects n=33, number of measurements n=99). Error category < 5 mmhg < 10 mmhg < 15 mmhg Required Two of All of Achieved SBP DBP
5 Table 2C: Number of subjects having the ESH-specified fraction of device-observer differences 5 mmhg for systolic (SBP) and diastolic (DBP) blood pressure (number of subjects 33) Subjects with specified fraction of device-observer differences 2/3 < 5 mmhg 0/3 < 5 mmhg Required Both 22 3 Achieved SBP 25 3 DBP
6 Table 3: Number of subjects obtained for each blood pressure category according to ESH and BHS criteria in the categorization measurement (BPA) and the following validation measurements (BP1 BP7) BPA BP1 BP3 BP5 BP7 ESH Systolic mmhg mmhg mmhg Diastolic mmhg mmhg mmhg BHS Systolic <100 mmhg mmhg mmhg mmhg >180 mmhg Diastolic < 60 mmhg mmhg mmhg mmhg >110 mmhg
7 Figure legends Figure 1: Tukey mean-difference plots (BHS validation process) of systolic (A) and diastolic (B) blood pressure difference of device and observer in 85 subjects (n=255 measurements). Mean difference for systolic blood pressure is -1.9 ± 6.6 mmhg, mean difference for diastolic blood pressure is 0.1 ± 5.8 mmhg. Figure 2: Tukey mean-difference plots (ESH validation process) of systolic (A) and diastolic (B) blood pressure difference of device and observer in 33 subjects (n=99 measurements). Mean device-observer differences were 0.0 ± 5.6 mmhg (systolic) and 1.0 ± 5.7 mmhg (diastolic). 24
8 Figures Figure 1A 25
9 Figure 1B 26
10 Figure 2 Figure 2A Figure 2B 27
Validation Study Result Form
Validation Study Result Form Please complete Section 1 to Section 5 of this form and return it to dabl Educational Trust with copies of the validation Study Ref. plots. In Section 3 to Section 5, complete
More informationDevice Equivalence Evaluation Form
Comparison of the Omron M6 Comfort IT (HEM-7322U-E) with the Omron M6 Comfort (HEM-7321-E) Devices Omron M6 Comfort IT (HEM-7322U-E) Omron M6 Comfort (HEM-7321-E) Pictures Display Validation ESH 2010 Device
More informationDevice Equivalence Evaluation Form
Comparison of the HARTMANN Veroval BPU22 with the AViTA BPM63S Devices Item 9 HARTMANN Veroval BPU22 AViTA BPM63S Pictures Display Image Validation Equivalence ESH 2010 ESH 2002 BHS AAMI Category Arm Type
More informationValidation of the OMRON 705 IT blood pressure measuring device according to the International Protocol of the European Society of Hypertension
Validation of the OMRON 705 IT blood pressure measuring device according to the International Protocol of the European Society of Hypertension M. EL ASSAAD, J. TOPOUCHIAN, G. LABAKI, R. ASMAR L Institut
More informationDevice Equivalence Evaluation Form
Device Equivalence Evaluation Form Comparison of the HARTMANN Veroval upper arm blood pressure monitor with the AViTA BPM63S Devices Pictures HARTMANN Veroval upper arm blood pressure monitor AViTA BPM63S
More informationMaker Spacelabs Healthcare Manufacturer Spacelabs Healthcare. Brand Spacelabs Model OnTrak
Validation Study Result Form Please complete Section 1 to Section 3 of this form and return it to dabl Educational Trust with copies of the validation plots and a digital photograph of the device used
More informationValidation Study Result Form
Validation Study Result Form Please complete Section 1 to Section 3 of this form and return it to dabl Educational Trust with copies of the validation plots. The requirements for each of these sections
More informationDevice Equivalence Evaluation Form
Device Equivalence Evaluation Form Comparison of the HARTMANN Veroval wrist blood pressure monitor with the AViTA BPM15S Devices HARTMANN Veroval wrist blood pressure monitor AViTA BPM15S Pictures Display
More informationDeclaration of Equivalence Form
Declaration of Equivalence Form DECLARATION OF BLOOD PRESSURE MEASURING DEVICE EQUIVALENCE 2013 SECTION A - Please complete all items. I Bill Huang,, Name of a Company Director A SIGNED COPY WILL BE POSTED
More informationDevice Equivalence Evaluation Form
Comparison of the HARTMANN Veroval BPW22 with the AViTA BPM15S Devices Item 9 HARTMANN Veroval BPW22 AViTA BPM15S Pictures Display Image Validation Equivalence ESH 2010 ESH 2002 BHS AAMI Category Wrist
More informationa Medical Physics Department, Guy s & St Thomas NHS Foundation Trust and b King s College School of Medicine, St Thomas Campus, London, UK
Devices and technology 27 Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol Andrew Coleman a, Paul Freeman
More informationDevice Equivalence Evaluation Form
Comparison of the SAFETY PRONTEX INTEGRA (Nissei DS-B33-03) with the Nissei DSK-1011 Devices Item 9 SAFETY PRONTEX INTEGRA (Nissei DS-B33-03) Nissei DSK-1011 Pictures Display Image Validation ESH IP2010
More informationValidation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension
Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation
More informationValidation Study Registration Form
TrUSt Validation Study Registration Form This form should be completed by the manufacturer or on behalf of the manufacturer. Study Investigator Details Name Address Mrs.Annemarie de Greef and Professor
More informationDevice Equivalence Evaluation Form
Comparison of the Microlife BP A150 AFIB with the Microlife BP A100 Plus and Microlife BP A100 Device Equivalence Evaluation Form Devices Microlife BP A150 AFIB 9 Microlife BP A100 Plus 9 Microlife BP
More information1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany
Page 1 of 9 Validation of the TONOPORT VI ambulatory blood pressure monitor, according to the European Society of Hypertension International Protocol revision 2010 Michael Abou-Dakn 1, Cornelius Döhmen
More informationSTATE OF THE ART BP ASSESSMENT
STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationDR JIRAR TOPOUCHIAN PROF PAROUNAK ZELVEIAN PROF ROLAND ASMAR. September 8 th, Principal Investigator and Study Chair:
Page 1 of 10 Validation of the automatic blood pressure measurements device, the OMRON EVOLV (HEM- 7600 T-E) in Pregnancy according to the Modified European Society of Hypertension International Protocol
More informationComparison of the Microlife A6 PC (BP3GU1-8Y) with the Microlife BP3BT0-A and Microlife BP A100 Plus
Comparison of the Microlife A6 PC (BP3GU1-8Y) with the Microlife BP3BT0-A and Microlife BP A100 Plus Devices Microlife A6 PC (BP3GU1-8Y) 9 BP3BT0-A 9 Microlife BP A100 Plus 9 Image 10 10 10 Validation
More informationCopyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Devices and technology 261 Validation of the ROSSMAX blood pressure measuring monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring
More informationBackBeat Cardiac Neuromodulation Therapy (CNT) for Immediate, Substantial and Sustained Lowering of Blood Pressure. Daniel Burkhoff MD PhD
BackBeat Cardiac Neuromodulation Therapy (CNT) for Immediate, Substantial and Sustained Lowering of Blood Pressure Daniel Burkhoff MD PhD Director Heart Failure, Hemodynamics and Mechanical Support Research
More informationComparison of the Microlife A2 Basic (BP3GQ1-3P) with the Microlife BP3BT0-A and Microlife BP A100 Plus
Comparison of the Microlife A2 Basic (BP3GQ1-3P) with the Microlife BP3BT0-A and Microlife BP A100 Plus Devices Microlife A2 Basic (BP3GQ1-3P) 9 BP3BT0-A 9 Microlife BP A100 Plus 9 Image 10 10 10 Validation
More informationMethods DEVICES AND TECHNOLOGY
DEVICES AND TECHNOLOGY Validation of the Omron HEM-907 device for blood pressure measurement Mohamed A. El Assaad, Jirar A. Topouchian, Bernadette M. Darné and Roland G. Asmar Background The aim of this
More informationSYNOPSIS. Publications No publications at the time of writing this report.
Drug product: TOPROL-XL Drug substance(s): Metoprolol succinate Study code: D4020C00033 (307A) Date: 8 February 2006 SYNOPSIS Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationReference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents
Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents Simonetti G.D. Istituto Pediatrico della Svizzera Italiana Ente Ospedaliero Cantonale e Università
More informationAppendix. Supplementary figures and tables
This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix. Supplementary figures and tables Figure A1. Flowchart describing patient
More informationAdherence to Hypertension Visit Protocol Description: % of patients with HTN who are being monitored through follow up visits according to guidelines, based on "days since last BP", which looks back from
More informationa Centre de Médecine Cardiovasculaire, Paris, France, b Lebanese Hospital and Received 7 June 2009 Revised 15 September 2009 Accepted 9 October 2009
42 Original article Validation of three professional devices measuring office blood pressure according to three different methods: the Omron BP, the Omron HBP T and the Pic Indolor Professional Roland
More information2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative
2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative February 2014 Patient Population Measure spec for MU/PD generally follows NQF 0018 (used for HEDIS, PQRS, and MU) 1.6
More informationADVANCE post trial ObservatioNal Study
Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute
More informationValidation study of the Dinamap ProCare 200 upper arm blood pressure monitor in children and adolescents
Original article http://dx.doi.org/10.3345/kjp.2011.54.11.463 Korean J Pediatr 2011;54(11):463-469 Validation study of the Dinamap ProCare 200 upper arm blood pressure monitor in children and adolescents
More informationand bias, which are known to be present in self-home and in professional office BP measurements taken using the auscultatory technique [7].
Devices and technology 37 Validation of the A&D UM-11 professional hybrid device for office blood pressure measurement according to the International Protocol George S. Stergiou, Periklis P. Giovas, Charilaos
More informationCopyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Devices and technology 57 Comparison of wrist-type and arm-type 24-h blood pressure monitoring devices for ambulatory use Takahiro Komori a, Kazuo Eguchi a, Satoshi Hoshide a, Bryan Williams b and Kazuomi
More informationBLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?
BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN? DECLARATION OF INTEREST Medical Director and Chairman, Advisory Board dabl Ltd., Dublin, Ireland. BLOOD PRESSURE MEASUREMENT
More informationQuality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care
Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Intermediate
More informationHCHS/SOL Submission Instructions for Manuscripts or Publications
HCHS/SOL Submission Instructions for Manuscripts or Publications What is this? This is an example of an ideal submission of manuscripts or publications on the HCHS/SOL website. This example describes the
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationA GUIDE TO OUR NIBP TECHNOLOGY
GE Healthcare THE DINAMAP DIFFERENCE A GUIDE TO OUR NIBP TECHNOLOGY OUR TECHNOLOGICAL ADVANTAGES THE OSCILLOMETRIC METHODOLOGY Oscillometry is the most commonly used means of indirect blood pressure measurement
More informationHypertension and the SPRINT Trial: Is Lower Better
Hypertension and the SPRINT Trial: Is Lower Better 8th Annual Orange County Symposium on Cardiovascular Disease Prevention Saturday, October 8, 2016 Keith C. Norris, MD, PhD, FASN Professor of Medicine,
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationTHE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)
THE NEW ARMENIAN MEDICAL JOURNAL Vol.5 (2011), Nо 2, p.29-34 DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) Zelveian P.H. 1, 2, Podosyan G.A. 2 1 Institute
More informationReceived 10 April 2008 Revised 23 June 2008 Accepted 24 June 2008
342 Original article Development of an accurate oscillometric blood pressure device for low resource settings Annemarie de Greeff, Hannah Nathan, Nina Stafford, Bing Liu and Andrew H. Shennan Objective
More informationHypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA
Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA Case 1 What should be your BP goal for an elderly (> 75 yrs of
More informationKDIGO Controversies Conference on Blood Pressure in CKD
KDIGO Controversies Conference on Blood Pressure in CKD September 7-10, 2017 Edinburgh, Scotland Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization whose mission is to improve
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationBlood Pressure Measurement Does it matter where you do it or how often?
Blood Pressure Measurement Does it matter where you do it or how often? James (Jim) M. Wright Coordinating Editor Cochrane Hypertension Group Conflict of Interest First half evidence based, no conflicts.
More informationCopyright Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Devices and technology 16 Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-71-E)
More informationBlood Pressure Acre Surgery Diviash Thakrar
Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise
More informationANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*
Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical
More informationABPM screen 300/400 Risk Assessment
ABPM screen 300/400 Risk Assessment Highlights of custo screen400 ABPM 24 hours Synchronized ABPM and Holter ECG recordings in combination with custo guard 3 72 hours for ABPM recordings alone To our knowledge,
More informationSUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
More information2. Measure a subject's blood pressure and heart rate both at rest and during exercise.
Lab Activity 11 The Cardiovascular System Student Learning Objectives After completing this lab, you should be able to: 1. Define, explain and correctly use the key terms. 2. Measure a subject's blood
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More informationThe Use of Alternative Therapies to Lower Blood Pressure in Older African Americans
The Use of Alternative Therapies to Lower Blood Pressure in Older African Americans Cardiovascular (CVD) disease is the leading cause of death in the USA, especially for African Americans, who have higher
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationCharles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT
Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis
More informationdoi: /fampra/cmw053
doi: 10.1093/fampra/cmw053 Manuscript type Original research Title Comparison of blood pressure measurements on the bare arm, over a sleeve, and over a rolled-up sleeve in the elderly Short title Blood
More informationOptimal blood pressure targets in chronic kidney disease
Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationThe introduction of oscillometric automated blood pressure
Atrial Fibrillation Impact of Atrial Fibrillation on the Accuracy of Oscillometric Blood Pressure Monitoring Nikolaos Pagonas,* Sven Schmidt,* Jörg Eysel, Friederike Compton, Clemens Hoffmann, Felix Seibert,
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationHome Blood Pressure Log
Home Blood Pressure Log 2 You or your health care professional may want to monitor your blood pressure at home twice a day for a week or more before appointments to accurately confirm your average blood
More informationSeasonal variation in blood pressure and its relationship with outdoor air temperature in 10 diverse regions of China: the China Kadoorie Biobank
Seasonal variation in blood pressure and its relationship with outdoor air temperature in diverse regions of China: the China Kadoorie Biobank SUPPLEMENTAL MATERIAL 1 Tables etable 1: Seasonal mean outdoor
More informationNew Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD
New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD None Disclosures Objectives Understand trend in blood pressure clinical practice guidelines
More informationCritical Review Form Therapy
Critical Review Form Therapy Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Lancet 1993; 341:501-511 Objective: To determine
More informationResearch Article Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study
SAGE-Hindawi Access to Research International Journal of Hypertension Volume 2010, Article ID 970694, 6 pages doi:10.4061/2010/970694 Research Article Prevalence, Awareness, Treatment, and Control of Hypertension
More informationBlood Pressure Measurement in SPRINT
Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT
More informationDoes masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients?
O R I G I N A L A R T I C L E Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients? I. Aksoy, J. Deinum, J.W.M. Lenders, Th. Thien *# Department of
More informationVital Signs. Vital Signs. Pulse. Temperature. Respiration. Blood Pressure
Vital Signs Jarvis, Chapter 9 Vital Signs Classic Vital Signs TPR/BP Temperature Pulse Respirations Blood Pressure Additional Vital Signs Height Weight BMI (Kg/m2) or (702Xlbs/in2) Supine, orthostatic
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
More informationImplications of Drug-related Increases in Blood Pressure
Implications of Drug-related Increases in Blood Pressure Preston M. Dunnmon, MD, FACP, FACC Division of Cardiovascular and Renal Products US Food and Drug Administration July 18, 2012 Disclaimer The findings
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationSystolic Blood Pressure Intervention Trial (SPRINT)
09:30-09:50 2016.4.15 Systolic Blood Pressure Intervention Trial (SPRINT) IN A NEPHROLOGIST S VIEW Sejoong Kim Seoul National University Bundang Hospital Current guidelines for BP control Lowering BP
More informationIRBES_R_04320 Generic drug name: Irbesartan + amlodipine Date: Study Code: 31 active centers: 20 in Korea, 7 in India and 4 in Philippines.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationHigh intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes Sophie Cassidy, s.cassidy@ncl.ac.uk 1) Concentric remodelling 1.2 * Eccentricity ratio
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationDEVICES AND TECHNOLOGY
DEVICES AND TECHNOLOGY Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor James M. Wright ab, Gurdial S. Mattu a, Thomas L. Perry Jr ab, Mark E. Gelfer
More informationHypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016
Hypertension targets in the elderly Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016 NICE (2011) Aim for a target clinic blood pressure below 150/90 mmhg in people aged 80
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationDesign and analysis of clinical trials
Design and analysis of clinical trials Lecture 3 1.Basic Design Considerations 2.Sample Size determinationa 3.Randomization 2018-01-31 Previous Lectures Definition of a clinical trial The drug development
More informationSupplementary Online Content
Supplementary Online Content Lewington S, Lacey B, Clarke R, et al; China Kadoorie Biobank Consortium. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern
More informationUse and Interpretation of Home Blood Pressure Monitoring
Use and Interpretation of Home Blood Pressure Monitoring BLOOD PRESSURE in year 2015 PARAMETERS TODAY Gianfranco Parati University of Milano-Bicocca & Ospedale S.Luca, IRCCS, Istituto Auxologico Italiano
More informationTheoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.
Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs
More informationMasked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology
Masked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology Giovanni Di Salvo MD, PhD, MMSc, FESC BACKGROUND MASKED HYPERTENSION Masked hypertension (MH) consists of an elevated
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationRevision of 10/27/2017 Form #280 Page 1 of 12 PVDOMICS STUDY Clinical Center Right Heart Catheterization (RHC) Results Form #280
Revision of 10/27/2017 Form #280 Page 1 of 12 PVDOMICS STUDY Clinical Center Right Heart Catheterization (RHC) Results Form #280 Instructions: Review PVDOMICS MOP Chapter 100 prior to completing right
More informationAdvances in Peritoneal Dialysis, Vol. 34, 2018
Advances in Peritoneal Dialysis, Vol. 34, 2018 Vasilios Vaios, 1 Panagiotis I. Georgianos, 1 Maria I. Pikilidou, 1 Theodoros Eleftheriadis, 2 Sotirios Zarogiannis, 3 Aikaterini Papagianni, 4 Pantelis E.
More informationAmbulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair
Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Review limitations of office BP in making a correct diagnosis of hypertension
More informationSpecial Lecture 10/28/2012
Special Lecture 10/28/2012 HYPERTENSION Dr. HN Mayrovitz Special Lecture 10/28/2012 Arterial Blood Pressure (ABP) - Definitions ABP Review Indirect Oscillographic Method Resistance (R), Compliance (C)
More informationInterested parties (organisations or individuals) that commented on the draft document as released for consultation.
23 June 2016 EMA/CHMP/345847/2015 Committee for Medicinal products for Human Use Overview of comments received on ''Guideline on clinical investigation of medicinal products in the treatment of hypertension'
More information